Forget What You Know About Probiotics - A Paradigm Shift
This talk was shown at the Autism One conference in May 2016.
Much of the probiotic market was built on assumptions and hypotheses of how the gut functions. With the $157 million NIH Human Microbiome Project dramatically changing our understanding of the gut in the last 5 years, we have come to discover that the assumptions and hypotheses under which the vast majority of probiotic products are formulated are simply false. We have a paradigm shift in our understanding of probiotic therapy.
This talk will discuss details of the new understanding of the human microbiome and how it specifically relates to health, including spectrum disorders. We ARE 10 times more bacteria than we are human, and the bacteria that live in an on us play a significant role in how our body responds to stress, food, and our environment. Our microbes control many of our behaviors and can even influence what we eat. A true understanding of the microbiome is critical to understanding the origins of many chronic and prevalent diseases. Health starts in the gut, and proper digestion and reaction to food is the keystone to a healthy lifestyle. Natural probiotics play a critical role in the function of the gut and the gut microbiome, but not all probiotics are created equal. In fact, the vast majority of probiotics cannot even be considered probiotics based on the scientific definition established by the World Health Organization.
Recent research has suggested an association between gut dysbiosis and the onset of autism spectrum disorders. Physician-supervised protocols using probiotic strains that alleviate dysbiosis have resulted in corresponding reports of clinical improvement of symptoms in children.
You will learn the latest understanding of the form and function of the human microbiome; how the microbiome influences the body, the mind, and health; and how most diseases starts in the gut.
Kiran Krishnan is a research microbiologist and has been involved in the dietary supplement and nutrition market for the past 16 years. He comes from a strict research background, having spent several years with hands-on R&D in the fields of molecular medicine and microbiology at the University of Iowa. Mr. Krishnan earned his bachelor of science degrees in microbiology at the University of Iowa; his undergraduate education was followed up with post graduate research in molecular biology and virology. He left university research to take a position as the U.S. business development and product development lead for Amano Enzyme, USA. Amano is one of the world’s largest suppliers of therapeutic enzymes used in the dietary supplement and pharmaceutical industries in North America. Kiran also established a clinical research organization where he designed and conducted over a dozen human clinical trials in human nutrition.
Kiran is a co-founder and partner in Nu Science Trading, LLC., a nutritional technology development, research and marketing company in the U.S. dietary supplement and medical food markets. Most recently, Kiran is acting as the chief scientific officer at Physician’s Exclusive, LLC. and Microbiome Labs. He is a frequent lecturer on the human microbiome at medical and nutrition conferences. He conducts the popular monthly microbiome series webinars through the Rebel Health Tribe and has been a guest speaker on several health summits as a microbiome expert. He is currently involved in 3 novel clinical trials on the probiotics and the human microbiome. Kiran brings his extensive knowledge and practical application of the latest science on the human microbiome as it relates to health and wellness. Kiran Krishnan has been involved in the development of the Just Thrive Probiotic formulation.
See also Probiotics